X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22352) 22352
Newsletter (2288) 2288
Book Review (1449) 1449
Publication (1439) 1439
Book Chapter (51) 51
Conference Proceeding (51) 51
Magazine Article (49) 49
Newspaper Article (32) 32
Dissertation (19) 19
Web Resource (7) 7
Trade Publication Article (6) 6
Government Document (3) 3
Data Set (2) 2
Streaming Video (2) 2
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19015) 19015
humans (14092) 14092
rifampin (9558) 9558
male (7228) 7228
rifampin - pharmacology (6926) 6926
rifampin - therapeutic use (6767) 6767
female (6400) 6400
adult (5235) 5235
tuberculosis (4973) 4973
middle aged (4033) 4033
microbiology (3713) 3713
rifampin - administration & dosage (3485) 3485
animals (3348) 3348
infectious diseases (3214) 3214
drug therapy, combination (3094) 3094
pharmacology & pharmacy (3011) 3011
tuberculosis, pulmonary - drug therapy (2570) 2570
mycobacterium tuberculosis - drug effects (2557) 2557
microbial sensitivity tests (2517) 2517
aged (2346) 2346
isoniazid - therapeutic use (2302) 2302
antitubercular agents - therapeutic use (2292) 2292
research (2285) 2285
adolescent (2099) 2099
abridged index medicus (1806) 1806
rifampin - adverse effects (1782) 1782
time factors (1738) 1738
drug resistance (1681) 1681
mutation (1651) 1651
rifampicin (1627) 1627
anti-bacterial agents - pharmacology (1620) 1620
tuberculosis - drug therapy (1611) 1611
antibiotics (1564) 1564
antitubercular agents - pharmacology (1553) 1553
treatment outcome (1478) 1478
analysis (1473) 1473
drug resistance, microbial (1440) 1440
drug therapy (1397) 1397
drug resistance in microorganisms (1381) 1381
anti-bacterial agents - therapeutic use (1371) 1371
child (1352) 1352
mice (1342) 1342
ethambutol - therapeutic use (1332) 1332
isoniazid (1329) 1329
mycobacterium tuberculosis - isolation & purification (1325) 1325
drugs (1276) 1276
mycobacterium tuberculosis - genetics (1252) 1252
respiratory system (1219) 1219
health aspects (1144) 1144
isoniazid - administration & dosage (1142) 1142
mycobacterium-tuberculosis (1136) 1136
drug interactions (1133) 1133
isoniazid - pharmacology (1112) 1112
diagnosis (1086) 1086
mycobacterium tuberculosis (1069) 1069
antitubercular agents - administration & dosage (1047) 1047
infections (1041) 1041
immunology (1033) 1033
infection (1012) 1012
bacteria (973) 973
drug resistance, bacterial (967) 967
pyrazinamide - therapeutic use (926) 926
pulmonary tuberculosis (919) 919
pharmacokinetics (911) 911
child, preschool (890) 890
medicine, general & internal (883) 883
care and treatment (852) 852
pyrazinamide (845) 845
medical research (833) 833
young adult (826) 826
risk factors (798) 798
antibiotics, antitubercular - therapeutic use (789) 789
antibiotics, antitubercular - pharmacology (788) 788
infant (753) 753
retrospective studies (753) 753
rifampin - pharmacokinetics (750) 750
sputum - microbiology (747) 747
kinetics (742) 742
streptomycin - therapeutic use (728) 728
therapy (727) 727
tuberculosis, multidrug-resistant - drug therapy (715) 715
drug administration schedule (705) 705
tuberculosis, pulmonary - microbiology (702) 702
medicine, experimental (699) 699
sensitivity and specificity (689) 689
strains (684) 684
rats (682) 682
bacterial proteins - genetics (673) 673
dosage and administration (671) 671
antitubercular agents - adverse effects (664) 664
ethambutol (662) 662
resistance (643) 643
anti-bacterial agents - administration & dosage (642) 642
leprosy - drug therapy (637) 637
dose-response relationship, drug (624) 624
escherichia coli - drug effects (616) 616
drug synergism (612) 612
medicine (611) 611
research article (607) 607
staphylococcal infections - drug therapy (607) 607
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21107) 21107
French (825) 825
Russian (594) 594
German (443) 443
Japanese (433) 433
Spanish (364) 364
Italian (321) 321
Chinese (203) 203
Polish (112) 112
Turkish (73) 73
Romanian (71) 71
Portuguese (57) 57
Korean (56) 56
Dutch (33) 33
Hebrew (17) 17
Norwegian (16) 16
Croatian (13) 13
Swedish (12) 12
Czech (11) 11
Danish (10) 10
Bulgarian (5) 5
Hungarian (5) 5
Ukrainian (5) 5
Finnish (4) 4
Persian (4) 4
Lithuanian (3) 3
Serbian (3) 3
Slovak (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 08/2017, Volume 15, Issue 8, p. 801
Zusammenfassung Lepra ist eine chronisch verlaufende, bakterielle Infektionskrankheit, die durch Mycobacterium (M.) leprae hervorgerufen wird. 2015 wurden... 
Rifampin
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1599 - 1608
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 2019, Volume 180, Issue 5, pp. 1262 - 1263
Thank you for your response to our letter. Your very recent study adds another twist to the discussion of Hidradenitis (HS) treatment with antibiotics. Based... 
Rifampin | Clindamycin
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 08/2018, Volume 52, Issue 2, p. 265
This study reports on the in vitro antituberculosis potential of 2-(((2-hydroxyphenyl) amino)methylene)-5,5-dimethylcyclohexane-1,3-dione (PAMCHD) against... 
Tuberculosis | Rifampin
Journal Article
International Journal of Infectious Diseases, ISSN 1201-9712, 04/2019, Volume 81, p. 236
To determine the proportion of rifampicin-resistant tuberculosis (RR-TB) patients who accessed second-line drug susceptibility testing (SL-DST) results... 
Tuberculosis | Rifampin
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9776, pp. 1495 - 1505
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 23, pp. 2155 - 2166
Journal Article
Journal Article
International Journal of Oral & Maxillofacial Surgery, ISSN 0901-5027, 2017, Volume 46, pp. 107 - 107
Journal Article
A validated high-performance liquid chromatography method for the determination of rifampicin and desacetyl rifampicin in plasma and urine, 08/2004
OBJECTIVE: To standardize a high-performance liquid chromatography (HPLC) method for the determination of rifampicin (RMP) and its major metabolite desacetyl... 
ph04076 Rifampin, rifamycin, HPLC | Pharmacology
Journal
by Lamb, R and Desai, N
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2015, Volume 72, Issue 5, pp. AB42 - AB42
Journal Article
Respirology, ISSN 1323-7799, 11/2018, Volume 23, Issue S2, pp. 6 - 6
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 04/2019, Volume 180, Issue 4, pp. 949 - 950
Linked Article: Albrecht et al. Br J Dermatol 2019; 180 :749–755 . 
DERMATOLOGY | Rifampin | Clindamycin
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 1, pp. 27 - 35
Summary Background Intensified antibiotic treatment might improve the outcome of tuberculous meningitis. We assessed pharmacokinetics, safety, and survival... 
Infectious Disease | MYCOBACTERIUM-TUBERCULOSIS | ETHAMBUTOL | INFECTIOUS DISEASES | IN-VITRO | PHARMACOKINETICS | LEVOFLOXACIN | PULMONARY TUBERCULOSIS | INFECTION | DRUG-RESISTANCE | CEREBROSPINAL-FLUID | CIPROFLOXACIN | Fluoroquinolones | Aza Compounds - pharmacokinetics | Antitubercular Agents - adverse effects | Rifampin - pharmacokinetics | Antibiotics, Antitubercular - adverse effects | Follow-Up Studies | Humans | Middle Aged | Aza Compounds - adverse effects | Male | Quinolines - administration & dosage | Quinolines - pharmacokinetics | Young Adult | Drug Therapy, Combination - adverse effects | Rifampin - adverse effects | Adult | Female | Rifampin - administration & dosage | Antibiotics, Antitubercular - administration & dosage | Aza Compounds - administration & dosage | Anti-Infective Agents - adverse effects | Antibiotics, Antitubercular - pharmacokinetics | Tuberculosis, Meningeal - drug therapy | Drug Administration Schedule | Drug Therapy, Combination - methods | Anti-Infective Agents - administration & dosage | Antitubercular Agents - pharmacokinetics | Anti-Infective Agents - pharmacokinetics | Adolescent | Antitubercular Agents - administration & dosage | Tuberculosis, Meningeal - metabolism | Quinolines - adverse effects | Indonesia | Tuberculosis | Meningitis | Dosage and administration | Product development | Moxifloxacin | Universities and colleges | Rifampin | Index Medicus
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 2019, Volume 180, Issue 5, pp. 1262 - 1262
We read with great interest the article by Albrecht et al. regarding the possible use of rifampicin monotherapy in Hidradenitis Suppurativa (HS). The combined... 
RESISTANCE | DERMATOLOGY | Rifampin | Clindamycin
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 1, pp. 11 - 20
In this study in South Africa, 1148 HIV-infected adults with TB were assigned to rifapentine–isoniazid weekly for 12 weeks, rifampin–isoniazid twice weekly for... 
TRIAL | TWICE | MEDICINE, GENERAL & INTERNAL | DOSE PHARMACOKINETICS | BOTSWANA | THERAPY | LATENT TUBERCULOSIS | PULMONARY TUBERCULOSIS | RIFAPENTINE | RIFAMPICIN | ISONIAZID PROPHYLAXIS | Rifampin - analogs & derivatives | Antitubercular Agents - adverse effects | Follow-Up Studies | Humans | Isoniazid - adverse effects | Drug Resistance, Bacterial | Male | Risk | Mycobacterium tuberculosis - drug effects | Cause of Death | Rifampin - adverse effects | Adult | Female | HIV Infections - mortality | Rifampin - administration & dosage | Drug Therapy, Combination | Anti-Retroviral Agents - therapeutic use | Tuberculosis, Multidrug-Resistant | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Isoniazid - administration & dosage | AIDS-Related Opportunistic Infections - prevention & control | Tuberculosis - prevention & control | Antitubercular Agents - administration & dosage | HIV Infections - drug therapy | Patient Compliance | Prevention | Control | Medical examination | Tuberculosis | South Africans | Causes of | Dosage and administration | Drug therapy | HIV infection | Isoniazid | Rifampin | Rifapentine | Antiretroviral drugs | Hypersensitivity | Multidrug resistance | Infections | Tuberculin | Drug resistance | Patients | Antiretroviral therapy | CD4 antigen | Infectious diseases | Womens health | Biopsy | Human immunodeficiency virus--HIV | Skin tests | Index Medicus | Abridged Index Medicus
Journal Article
JAMA Pediatrics, ISSN 2168-6203, 03/2015, Volume 169, Issue 3, pp. 247 - 255
Journal Article